StrataPATH™ (Precision Indications for Approved Therapies)

Stopped early · Phase 2

Conditions studied: Cancer, Advanced Solid Tumor

In brief

StrataPATH™ is a non-randomized, open-label trial designed to explore efficacy and safety of multiple FDA-approved and commercially available cancer therapies in new, biomarker-guided patient populations.

Key facts

Study ID

NCT05097599

Run by

Strata Oncology

People needed

11

Starts

2022-04-29

Expected to finish

2024-06-12

Last updated by the study team

2025-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Florida Cancer Specialists - North — St. Petersburg, Florida, United States
• Florida Cancer Specialists - Panhandle — Tallahassee, Florida, United States
• Kettering Health Network — Kettering, Ohio, United States
• University of Wisconsin — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.